Cyclooxygenase-2 and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn pigs

Journal of Applied Physiology

Volumn 98, Issue 3, 2005, Pages 1111-1118

  Fike, Candice D ^a   Kaplowitz, Mark R ^a   Zhane, Yongmei ^a   Pfister, Sandra L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acid metabolites; NS 398; Prostacyclin; Thromboxane

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTACYCLIN; THROMBOXANE;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; LUNG ARTERY; LUNG VASOCONSTRICTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SWINE;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; ARACHIDONIC ACID; CHRONIC DISEASE; CYCLOOXYGENASE 2; HYPERTENSION, PULMONARY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SWINE; TISSUE DISTRIBUTION;

EID: 14144255937     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00810.2004     Document Type: Article

References (37)

1. Adeagbo ASO, Patel D, Iddrissu A, Walker J, Thirumalai S, Joshua IG, Schuschke D, and Wang Y. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium. Eur J Pharmacol 458: 145-154, 2003.
2. Baber SR, Champion HD, Bivalacqua TJ, Hyman AL, and Kadowitz PJ. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds. Circulation 108: 896-901, 2003.
3. Baber SR, Hyman AL, and Kadowitz PJ. Role of COX-1 and COX-2 in prostanoid generation and modulation of angiotensin II responses. Am J Physiol Heart Circ Physiol 285: H2399-H2410, 2003.
4. 1, IL-1, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283: L717-L725, 2002.
5. Brannon TS, MacRitchie A, Jaramillo MA, Sherman TS, Yuhanna IS, Margraf LR, and Shaul PW. Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung. Am J Physiol Lung Cell Mol Physiol 274: L66-L71, 1998.
6. Brannon TS, North AJ, Wells LB, and Shaul PW. Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression. J Clin Invest 93: 2230-2235, 1994.
7. Campbell WB and Ojeda SR. Measurement of prostaglandin by radioimmunoassay. Methods Enzymol 141: 323-341, 1987.
8. Chenevard R, Hurlimann D, Bechir M, Enseleit F, Kpieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, Michel B, Luscher TF, Noll G, and Ruschitzka F. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 107: 405-409, 2003.
9. Chida M and Voelkel NF. Effects of acute and chronic hypoxia on rat lung cyclooxygenase. Am J Physiol Lung Cell Mol Physiol 270: L872-L878, 1996.
10. Clyman RI, Hardy P, Waleh N, Chen YQ, Mauray F, Fouron J, and Chemtob S. Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus. Am J Physiol Regul Integr Comp Physiol. 276: R913-R921, 1999.
11. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, and Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
12. Ermert L, Ermert M, Althoff A, Merkle M, Grimminger F, and Seeger W. Vasoregulatory prostanoid generation proceeds via cyclooxygenase-2 in non inflamed rat lungs. J Pharmacol Exp Ther 286: 1309-1314, 1998.
13. Ermert L, Ermert M, Goppelt-Struebe M, Walmrath D, Grimminger F, Steudel W, Ghofrani HA, Hornberger C, Duncker HR, and Seeger W. Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol 18: 479-488, 1998.
14. Felder CC. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9: 619-625, 1995.
15. Fike CD and Kaplowitz MR. Effect of chronic hypoxia on pulmonary vascular pressures in isolated lungs of newborn pigs. J Appl Physiol 77: 2853-2862, 1994.
16. Fike CD and Kaplowitz MR. Chronic hypoxia alters nitric oxide-dependent pulmonary vascular responses in lungs of newborn pigs. J Appl Physiol 81: 2078-2087, 1996.
17. Fike CD, Kaplowitz MR, Campbell WB, and Pfister SL. Role of cyclooxygenase-dependent contracting factor in the altered responses to acetylcholine of small pulmonary arteries from chronically hypoxic pigs (Abstract). FASEB J 13: A826, 1999.
18. Fike CD, Kaplowitz MR, and Pfister SL. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. Am J Physiol Lung Cell Mol Physiol 284: L316-L323, 2003.
19. Fike CD, Pfister SL, Kaplowitz MR, and Madden JA. Cyclooxygenase contracting factors and altered pulmonary vascular responses in chronically hypoxic newborn pigs. J Appl Physiol 92: 67-74, 2002.
20. Guerguerian AM, Hardy P, Bhattacharya M, Olley P, Clyman RI, Fouron JC, and Chemtob S. Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs. Am J Obstet Gynecol 179: 1618-1626, 1998.
21. Gust R, Kozlowski JK, Stephenson AH, and Schuster DP. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am J Respir Crit Care Med 160: 1165-1170, 1999.
22. Guyton JR, Dao DT, and Kindsay KL. Endothelial denudation and myointimal thickening in the rat carotid artery induced by the passage of bubbles. Exp Mol Pathol 40: 340-348, 1984.
23. Lassus P, Wolff H, and Andersson S. Cyclooxygenase-2 in human perinatal lung. Pediatr Res 47: 602-605, 2000.
24. Loftin CD, Trivedi DB, Tiano HF, Clark JA, Lee CA, Epstein JA, Morham SG, Brejer MD, Nguyen M, Hawkins BM, Goulet JL, Smithies O, Koller BH, and Langenbach R. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci USA 98: 1059-1064, 2001.
25. Matz RL, de Sotomayor MA, Schott C, Stoclet J, and Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 131: 303-311, 2000.
26. North AJ, Brannon TS, Wells LB, Campbell WB, and Shaul PW. Hypoxia stimulates prostacyclin synthesis in newborn pulmonary artery endothelium by increasing cyclooxygenase-1 protein. Circ Res 75: 33-40, 1994.
27. Parfenova H, Balabanova L, and Leffler CW. Posttranslational regulation of cyclooxygenase by tyrosin phosphorylation in cerebral endothelial cells. Am J Physiol Cell Physiol 274: C72-C81, 1998.
28. Parfenova H, Edison TH, and Leffler CJ. Upregulation of COX-2 in cerebral microvascular endothelial cells by smooth muscle cell signals. Am J Physiol Cell Physiol 273: C277-C288, 1997.
29. Parfenova H, Massie V, and Leffler CW. Developmental changes in endothelium-derived vasorelaxant factors in cerebral circulation. Am J Physiol Heart Circ Physiol 278: H780-H788, 2000.
30. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, and Breyer MD. Opposite effects of cyclooxygenase-1 and cyclooxygenase-2 activity on the pressor responses to angiotensin II. J Clin Invest 110: 61-69, 2002.
31. Quilley J and Chen Y. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 42: 837-843, 2003.
32. Schuster VL. Molecular mechanisms of prostaglandin transport. Annu Rev Physiol 60: 221-242, 1998.
33. Sherman TS, Chen Z, Yuhanna IS, Lau KS, Margraf LR, and Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol Lung Cell Mol Physiol 276: L383-L390, 1999.
34. Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M, Maxwell C, Palmisano J, Keaney JF, Morrow JD, and Vita JA. Short and long term COX 2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension 42: 310-315, 2003.
35. Zerrouk A, Auguet M, and Chabrier P. Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite. J Cardiovasc Pharmacol 31: 525-533, 1998.
36. Zhu D, Birks EK, Dawson CA, Patel M, Falck JR, Presberg K, Roman RJ, and Jacobs ER. Hypoxic pulmonary vasoconstriction is modified by P-450 metabolites. Am J Physiol Heart Circ Physiol 279: H1526-H1533, 2000.
37. Zhu D, Medhora M, Campbell WB, Spitzbarth N, Baker JE, and Jacobs ER. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 92: 992-1000, 2003.